Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults

Research output: Contribution to conferencePosterResearchpeer-review

Standard

Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults. / Roager, Henrik Munch; Vitaglione, Paola; Ercolini, Danilo; Dragsted, Lars Ove.

2018. P60 Poster session presented at 1st Nordic Metabolomics Conference, Örebro, Sweden.

Research output: Contribution to conferencePosterResearchpeer-review

Harvard

Roager, HM, Vitaglione, P, Ercolini, D & Dragsted, LO 2018, 'Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults', 1st Nordic Metabolomics Conference, Örebro, Sweden, 26/08/2018 - 28/08/2018 pp. P60.

APA

Roager, H. M., Vitaglione, P., Ercolini, D., & Dragsted, L. O. (2018). Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults. P60. Poster session presented at 1st Nordic Metabolomics Conference, Örebro, Sweden.

Vancouver

Roager HM, Vitaglione P, Ercolini D, Dragsted LO. Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults. 2018. Poster session presented at 1st Nordic Metabolomics Conference, Örebro, Sweden.

Author

Roager, Henrik Munch ; Vitaglione, Paola ; Ercolini, Danilo ; Dragsted, Lars Ove. / Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults. Poster session presented at 1st Nordic Metabolomics Conference, Örebro, Sweden.1 p.

Bibtex

@conference{91cae49770b745f59026df74e8b8d3fb,
title = "Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults",
abstract = "Diet-induced effects on the intestinal and systemic metabolome upon adherence to the Mediterranean diet (Med-D) may be beneficial for maintaining cardiovascular health. To investigate the effects of the Med-D compared to habitual diet on the intestinal and systemic metabolome, we conducted a randomized controlled parallel trial in 82 overweight or obese men and women with no known history of cardiovascular disease. Each subject in the Med-D group was assigned a personalized diet prepared on the basis of his/her habitual diet. Energy values and whole macronutrient composition were unchanged during the Med-D intervention. Feces, urine and blood samples were collected from all participants at baseline, after 4 and 8 weeks intervention. The samples were subjected to untargeted metabolomics using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-MS). Among the metabolites changing with the Med-D, we identified several food biomarkers confirming compliance including reduced levels of carnitine (reflecting reduced meat intake), increased levels of alkylresorcinols (reflecting increased wholegrain intake), increased levels of Urolithin A-3-O-glucuronide (reflecting increased nut intake). Furthermore, the Med-D resulted in reduced levels of the host-microbial co-metabolite p-cresol-sulfate (reflecting reduced colonic proteolysis) as well as changes in the primary bile acid, chenodeoxycholic acid-3-sulfate (suggesting altered bile acid biosynthesis and/or excretion), and reduced acyl-carnitines (possibly reflecting reduced beta-oxidation). Finally, the Med-D resulted in a changed tryptophan metabolism as reflected by alterations in both microbially derived tryptophan catabolites as well as in host tryptophan metabolites. Collectively, these alterations confirm that a Med-D changes the intestinal and systemic metabolome by changing circulating levels of food biomarkers, microbial metabolites and host metabolites.",
author = "Roager, {Henrik Munch} and Paola Vitaglione and Danilo Ercolini and Dragsted, {Lars Ove}",
note = "CURIS 2018 NEXS 340; null ; Conference date: 26-08-2018 Through 28-08-2018",
year = "2018",
month = aug,
day = "26",
language = "English",
pages = "P60",

}

RIS

TY - CONF

T1 - Mediterranean diet changes the intestinal and systemic metabolome in overweight/obese adults

AU - Roager, Henrik Munch

AU - Vitaglione, Paola

AU - Ercolini, Danilo

AU - Dragsted, Lars Ove

N1 - CURIS 2018 NEXS 340

PY - 2018/8/26

Y1 - 2018/8/26

N2 - Diet-induced effects on the intestinal and systemic metabolome upon adherence to the Mediterranean diet (Med-D) may be beneficial for maintaining cardiovascular health. To investigate the effects of the Med-D compared to habitual diet on the intestinal and systemic metabolome, we conducted a randomized controlled parallel trial in 82 overweight or obese men and women with no known history of cardiovascular disease. Each subject in the Med-D group was assigned a personalized diet prepared on the basis of his/her habitual diet. Energy values and whole macronutrient composition were unchanged during the Med-D intervention. Feces, urine and blood samples were collected from all participants at baseline, after 4 and 8 weeks intervention. The samples were subjected to untargeted metabolomics using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-MS). Among the metabolites changing with the Med-D, we identified several food biomarkers confirming compliance including reduced levels of carnitine (reflecting reduced meat intake), increased levels of alkylresorcinols (reflecting increased wholegrain intake), increased levels of Urolithin A-3-O-glucuronide (reflecting increased nut intake). Furthermore, the Med-D resulted in reduced levels of the host-microbial co-metabolite p-cresol-sulfate (reflecting reduced colonic proteolysis) as well as changes in the primary bile acid, chenodeoxycholic acid-3-sulfate (suggesting altered bile acid biosynthesis and/or excretion), and reduced acyl-carnitines (possibly reflecting reduced beta-oxidation). Finally, the Med-D resulted in a changed tryptophan metabolism as reflected by alterations in both microbially derived tryptophan catabolites as well as in host tryptophan metabolites. Collectively, these alterations confirm that a Med-D changes the intestinal and systemic metabolome by changing circulating levels of food biomarkers, microbial metabolites and host metabolites.

AB - Diet-induced effects on the intestinal and systemic metabolome upon adherence to the Mediterranean diet (Med-D) may be beneficial for maintaining cardiovascular health. To investigate the effects of the Med-D compared to habitual diet on the intestinal and systemic metabolome, we conducted a randomized controlled parallel trial in 82 overweight or obese men and women with no known history of cardiovascular disease. Each subject in the Med-D group was assigned a personalized diet prepared on the basis of his/her habitual diet. Energy values and whole macronutrient composition were unchanged during the Med-D intervention. Feces, urine and blood samples were collected from all participants at baseline, after 4 and 8 weeks intervention. The samples were subjected to untargeted metabolomics using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-MS). Among the metabolites changing with the Med-D, we identified several food biomarkers confirming compliance including reduced levels of carnitine (reflecting reduced meat intake), increased levels of alkylresorcinols (reflecting increased wholegrain intake), increased levels of Urolithin A-3-O-glucuronide (reflecting increased nut intake). Furthermore, the Med-D resulted in reduced levels of the host-microbial co-metabolite p-cresol-sulfate (reflecting reduced colonic proteolysis) as well as changes in the primary bile acid, chenodeoxycholic acid-3-sulfate (suggesting altered bile acid biosynthesis and/or excretion), and reduced acyl-carnitines (possibly reflecting reduced beta-oxidation). Finally, the Med-D resulted in a changed tryptophan metabolism as reflected by alterations in both microbially derived tryptophan catabolites as well as in host tryptophan metabolites. Collectively, these alterations confirm that a Med-D changes the intestinal and systemic metabolome by changing circulating levels of food biomarkers, microbial metabolites and host metabolites.

M3 - Poster

SP - P60

Y2 - 26 August 2018 through 28 August 2018

ER -

ID: 201151895